Search Results

Your search for Syed Ali Abutalib, MD, and Julie M. Vose, MD, MBA, FASCO matches 2 pages

Showing 1 - 2

By Syed Ali Abutalib, MD, and Julie M. Vose, MD, MBA, FASCO / March 25, 2021

Challenges in Managing Hodgkin Lymphoma: Focus on Use of Brentuximab Vedotin

“I was taught that the way of progress was neither swift nor easy.” —Marie Curie To complement The ASCO Post’s continued comprehensive coverage of the 2020 American Society of Hematology (ASH) Annual Meeting & Exposition, here are two abstracts selected from the meeting proceedings focusing on...

lymphoma

immunotherapy

By Syed Ali Abutalib, MD, and Julie M. Vose, MD, MBA, FASCO / February 25, 2021 / 2020 ASH Annual Meeting & Exposition

B-Cell and T-Cell Non-Hodgkin Lymphomas

To complement The ASCO Post’s continued comprehensive coverage of the 2020 American Society of Hematology (ASH) Annual Meeting & Exposition, here are several abstracts selected from the meeting proceedings focusing on the assessment and treatment of patients with B-cell and T-cell non-Hodgkin...

Apr

Today In Oncology

Search Results

Your search for Syed Ali Abutalib, MD, and Julie M. Vose, MD, MBA, FASCO matches 2 pages

Challenges in Managing Hodgkin Lymphoma: Focus on Use of Brentuximab Vedotin

B-Cell and T-Cell Non-Hodgkin Lymphomas

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs

AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer

In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer

Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved

Potential Protective Effects of Aspirin Against Colorectal Cancer